Last reviewed · How we verify
NCT03295656
Contrast-Enhanced Ultrasound Diagnosis of Acute Appendicitis
Phase 1 trial testing Sulfur hexafluoride lipid-type A microspheres in Appendicitis Acute. Withdrawn.
15 July 2020
Quick facts
| Lead sponsor | Boston Children's Hospital |
|---|---|
| Phase | Phase 1 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Start date | 15 July 2020 |
| Primary completion | 15 July 2020 |
| Estimated completion | 15 July 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Sulfur hexafluoride lipid-type A microspheres — full drug profile →
Conditions studied
- Appendicitis Acute — all drugs for Appendicitis Acute →
Sponsor
Boston Children's Hospital
Who can join
Adults 8 to 17, any sex, with Appendicitis Acute. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the ability of contrast-enhanced ultrasound to improve the diagnosis of acute appendicitis in children compared to conventional ultrasound.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03295656
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sulfur hexafluoride lipid-type A microspheres
Trials testing the same drug.
- NCT04640038 — Contrast Enhanced Ultrasound in COVID-19 · Phase 3 · completed
- NCT03549520 — CEUS Evaluation of Hypoxic Ischemic Injury · Phase 3 · completed
- NCT03549507 — CEUS Evaluation of Bowel Perfusion in Necrotizing Enterocolitis · Phase 3 · terminated
- NCT03687502 — The Role of Contrast Enhanced Ultrasound in Appendicitis · Phase 2 · completed
Other recruiting trials for Appendicitis Acute
Currently open trials in the same condition.
- NCT07521969 — Out-patiente Management for Gangrenous Acute Appendicitis: The PENDI-CSI II Randomized Clinical Trial. · NA · recruiting
- NCT06815822 — Prevention of Postoperative Hernias in Emergency Surgery · recruiting
- NCT06948071 — Enhanced Recovery After Surgery (ERAS) for Complicated Appendicitis · NA · recruiting
- NCT06762275 — The Impact of a Diagnostic Strategy for Acute Appendicitis in Children With Acute Abdominal Pain in Primary Care · NA · recruiting
- NCT06395636 — Early Detection of Infection Using the Fitbit in Pediatric Surgical Patients · NA · recruiting
Other Boston Children's Hospital trials
Trials by the same sponsor.
- NCT06804382 — Academic Detailing to Optimize PrEP Implementation in Pediatric Primary Care Settings: ADOPT-PrEP · NA · not yet recruiting
- NCT05113394 — Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy · Phase 2 · withdrawn
- NCT06434220 — Effect of Predictive Model on ED Physician Assessments of Patient Disposition · NA · not yet recruiting
- NCT07476430 — Readiness Outcomes Affecting Return to Sport 3.0 · NA · not yet recruiting
- NCT06706336 — Radon Asthma Intervention Trial · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03295656 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Boston Children's Hospital
- Last refreshed: 17 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03295656.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing